For the Inventor, By the Inventor

Enter assignee name

Ballerup, Denmark

Leo Pharmaceutical Products Ltd. A/s

USPTO Granted Patents = 38

Forward Citations = 303

Loading Chart...

Loading Chart...

35 inventors (with patents filed for the assignee):

Welf Von Daehne (6 out of 19 patents)

Erik Rytter Ottosen (5 out of 16 patents)

Ernst T Binderup (4 out of 16 patents)

4. Charlotte Schou Hunneche (3 out of 4 patents)

5. Mette Knak Christensen (2 out of 5 patents)

6. Kai Holst Hansen (2 out of 8 patents)

7. Claus Aage Svensgaard Bretting (2 out of 4 patents)

8. Gert Høy (2 out of 2 patents)

9. Erik Johannes Didriksen (2 out of 3 patents)

10. Tore Duvold (2 out of 2 patents)

11. Erik T Hansen (2 out of 6 patents)

12. Peter Werner Feit (2 out of 9 patents)

13. Herta Bruun (2 out of 6 patents)

14. Ole Bent Nielsen (2 out of 11 patents)

15. Poul Rodbroe Rasmussen (2 out of 4 patents)

38 patents: Sort by Forward Citations

1. 6787529 - Topical composition (2004-09-07),

2. 6753013 - Pharmaceutical composition (2004-06-22),

3. 6750253 - Aminobenzophenones as inhibitors of il-1&bgr; and tnf-&agr; (2004-06-15),

4. 6673783 - Fusidic acid derivatives (2004-01-06),

5. 6646143 - Vitamin D analogues (2003-11-11),

6. 6646129 - Cyanoguanidines as cell proliferation inhibitors (2003-11-11),

7. 6593319 - Fusidic acid derivatives (2003-07-15),

8. 6573255 - Vitamin D analogues (2003-06-03),

9. 6541670 - Aminobenzophenones as inhibitors of IL 1&bgr; and TNF-&agr; (2003-04-01),

10. 6525077 - Cyanoguanidine prodrugs (2003-02-25),

11. 6521606 - Matrix metalloproteinase inhibitors (2003-02-18),

12. 6486137 - Oligosaccharide mixtures having antithrombotic activity (2002-11-26),

13. 6432962 - Benzophenones as inhibitors of IL-1&bgr; and TNF-&agr; (2002-08-13),

14. 6379330 - Container for a hypodermic syringe (2002-04-30),

15. 6346541 - Cyanoguanidines as cell proliferation inhibitors (2002-02-12),

Leo Pharmaceutical Products Ltd. A/S is a global Danish pharmaceutical company specializing in dermatology and critical care. With a legacy of more than 100 years, Leo Pharma aims to improve the lives of people with skin diseases and critical care needs. Through innovative research, development, and manufacturing of dermatological and critical care products, they strive to help patients achieve healthier skin and a higher quality of life.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

38 Patents

#8 in Ballerup

#82 in Denmark

#17,275 in the World

Ballerup, Denmark

Leo Pharmaceutical Products Ltd. A/s

Forward Citations = 303

35 inventors:

Welf Von Daehne (6 out of 19 patents)

Erik Rytter Ottosen (5 out of 16 patents)

Ernst T Binderup (4 out of 16 patents)

4. Charlotte Schou Hunneche (3 out of 4 patents)

5. Mette Knak Christensen (2 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…